Literature DB >> 485196

Carrier detection in Duchenne muscular dystrophy. Evidence from a study of obligatory carriers and mothers of isolated cases.

J R Sibert, P S Harper, R J Thompson, R G Newcombe.   

Abstract

The mean levels of serum creatinine phosphokinase (CPK) were studied in three groups of women: normal controls (57), obligate carriers for Duchenne muscular dystrophy (30), and mothers of isolated cases of this disease (35). The distribution of the levels in these groups was significantly different and was in keeping with the hypothesis that one-third of isolated cases result from new mutations. The control and carrier ranges overlapped considerably, with the level of CPK of 33% of obligate carriers coming within the 97 1/2 centile of the normal range. Odds against an individual being a carrier were derived for specific mean values of CPK. They should be considered with genetic information using Bayes's theorem. The mean CPK levels in obligate carriers showed significant familial clustering. This may have implications in carrier detection.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 485196      PMCID: PMC1545480          DOI: 10.1136/adc.54.7.534

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  8 in total

1.  CREATINE KINASE LEVELS IN WOMEN WHO CARRY GENES FOR THREE TYPES OF MUSCULAR DYSTROPHY.

Authors:  K M WILSON; K A EVANS; C O CARTER
Journal:  Br Med J       Date:  1965-03-20

2.  Carrier detection in Duchenne muscular dystrophy.

Authors:  A D Roses; M J Roses; S E Miller; K L Hull; S H Appel
Journal:  N Engl J Med       Date:  1976-01-22       Impact factor: 91.245

3.  Genetic counselling in X-linked muscular dystrophy.

Authors:  A E Emery
Journal:  J Neurol Sci       Date:  1969 May-Jun       Impact factor: 3.181

4.  The biochemical identification of the carrier state in X-linked recessive (Duchenne) muscular dystrophy.

Authors:  W H Thomson
Journal:  Clin Chim Acta       Date:  1969-11       Impact factor: 3.786

5.  An assessment of the creatine kinase test in the detection of carriers of Duchenne muscular dystrophy.

Authors:  M W Thompson; E G Murphy; P J McAlpine
Journal:  J Pediatr       Date:  1967-07       Impact factor: 4.406

6.  The detection of carriers of X-linked muscular dystrophy genes. A review of some methods studied in Newcastle upon Tyne.

Authors:  D Gardner-Medwin; R J Pennington; J N Walton
Journal:  J Neurol Sci       Date:  1971-08       Impact factor: 3.181

7.  Systemic membrane defect in the proximal muscular dystrophies.

Authors:  N A Pickard; H D Gruemer; H L Verrill; E R Isaacs; M Robinow; W E Nance; E C Myers; B Goldsmith
Journal:  N Engl J Med       Date:  1978-10-19       Impact factor: 91.245

8.  Use of creatine kinase for detecting severe X-linked muscular dystrophy carriers.

Authors:  N R Dennis; K Evans; B Clayton; C O Carter
Journal:  Br Med J       Date:  1976-09-04
  8 in total
  8 in total

1.  Duchenne muscular dystrophy in Wales: a 15 year study, 1971 to 1986.

Authors:  A M Norman; C Rogers; J R Sibert; P S Harper
Journal:  J Med Genet       Date:  1989-09       Impact factor: 6.318

2.  The significance of simultaneous estimation of serum creatine kinase and myoglobin in neuromuscular diseases.

Authors:  P Diószeghy; F Mechler
Journal:  J Neurol       Date:  1988-01       Impact factor: 4.849

3.  The use of flanking markers in prediction for Duchenne muscular dystrophy.

Authors:  H Williams; M Sarfarazi; C Brown; N Thomas; P S Harper
Journal:  Arch Dis Child       Date:  1986-03       Impact factor: 3.791

4.  A genetic study of Duchenne muscular dystrophy in West Midlands.

Authors:  S Bundey
Journal:  J Med Genet       Date:  1981-02       Impact factor: 6.318

5.  The genetic status of mothers of isolated cases of Duchenne muscular dystrophy.

Authors:  R J Lane; M Robinow; A D Roses
Journal:  J Med Genet       Date:  1983-02       Impact factor: 6.318

6.  Linkage analysis of polymorphisms within the DNA fragment XJ cloned from the breakpoint of an X;21 translocation associated with X linked muscular dystrophy.

Authors:  M W Thompson; P N Ray; B Belfall; C Duff; C Logan; I Oss; R G Worton
Journal:  J Med Genet       Date:  1986-12       Impact factor: 6.318

7.  The application of linkage analysis to genetic counselling in families with Duchenne or Becker muscular dystrophy.

Authors:  S Hodgson; A Walker; C Cole; K Hart; L Johnson; J Heckmatt; V Dubowitz; M Bobrow
Journal:  J Med Genet       Date:  1987-03       Impact factor: 6.318

8.  Parental DNA sequence is critical family history in clinical genomics.

Authors:  Michael F Murray
Journal:  Genet Med       Date:  2016-01-14       Impact factor: 8.822

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.